Back to GetFilings.com



Table of Contents

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549




FORM 10-Q

  x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d)
OF THE SECURITIES EXCHANGE ACT OF 1934
 
 
For the quarterly period ended June 30, 2002
 
  o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d)
OF THE SECURITIES EXCHANGE ACT OF 1934
 
 
For the transition period from ________ to ________ .
 
Commission file number 000-23783
 
 
MICROMUSE INC.
(Exact name of registrant as specified in its charter)
   
DELAWARE 94-3288385


(State or other jurisdiction of
incorporation or organization)
(IRS Employer Identification No.)
   

139 TOWNSEND STREET
SAN FRANCISCO, CALIFORNIA 94107
(415) 538-9090
(Address, including ZIP code, and telephone number)


Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15 (d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Yes   x     No  o

74,737,662 shares of Common Stock, $0.01 par value, were outstanding as of July 31, 2002.



Table of Contents

MICROMUSE INC.


TABLE OF CONTENTS

     
    Page
PART  I - Financial Information
     
Item 1. Condensed Consolidated Financial Statements:  
     
         Condensed Consolidated Balance Sheets as of June 30, 2002 and September 30, 2001 3
     
         Condensed Consolidated Statements of Operations for the three and nine months ended June 30, 2002 and 2001 4
     
         Condensed Consolidated Statements of Cash Flows for the nine months ended June 30, 2002 and 2001 5
     
         Notes to Condensed Consolidated Financial Statements 6
     
     
Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations 10
     
     
Item 3. Quantitative and Qualitative Disclosures about Market Risk 30
     
     
     
PART  II - Other Information
     
Item 1. Legal Proceedings 31
     
Item 2. Changes in Securities and Use of Proceeds 31
     
Item 3. Defaults upon Senior Securities 31
     
Item 4. Submission of Matters to a Vote of Security Holders 31
     
Item 5. Other Information 31
     
Item 6. Exhibits and Reports on Form 8-K 32
     
Signatures 33
     

2


Table of Contents

Part I – FINANCIAL INFORMATION
      Item 1. Condensed Consolidated Financial Statements

MICROMUSE INC.

CONDENSED CONSOLIDATED BALANCE SHEETS
(In thousands, except per share data)
(Unaudited)

ASSETS
  June 30,   September 30,
  2002   2001
 
 
Current assets:              
     Cash and cash equivalents $ 110,672     $ 138,581  
     Short-term investments   35,702       16,109  
     Billed receivables, net   23,175       31,067  
     Prepaid expenses and other current assets   10,306       15,656  
 
   
 
        Total current assets   179,855       201,413  
               
     Property and equipment, net   11,025       15,221  
     Long-term investments   47,982       20,891  
     Goodwill and other intangible assets, net   27,809       36,113  
 
   
 
  266,671     $  273,638  
 
   
 
               
LIABILITIES AND STOCKHOLDERS' EQUITY
               
Current liabilities:              
     Accounts payable $ 1,265     $ 5,686  
     Accrued expenses   15,891       27,407  
     Income taxes payable   6,153       6,152  
     Deferred revenue   38,872       34,212  
 
   
 
        Total current liabilities   62,181       73,457  
               
Stockholders' equity              
     Preferred stock; $0.01 par value; 5,000 shares authorized;              
        no shares issued and outstanding   -       -  
     Common stock; $0.01 par value; 200,000 shares authorized;              
        74,730 and 73,903 shares outstanding as of June 30,              
        2002 and September 30, 2001, respectively   747       739  
     Additional paid–in capital   192,862       187,755  
     Treasury stock   (2,657 )     (2,657 )
     Accumulated other comprehensive loss   (2,179 )     (1,317 )
     Retained earnings   15,717       15,661  
 
   
 
        Total stockholders' equity   204,490       200,181  
 
   
 
  266,671     $  273,638  
 
   
 
               
See accompanying notes to the condensed consolidated financial statements

3


Table of Contents

MICROMUSE INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(In thousands, except per share data)
(Unaudited)
                           
  Three months ended   Nine months ended
  June 30,   June 30,
 
 
  2002   2001   2002     2001
 
 
 
 
Revenues:                          
     License $ 20,077     $ 46,412   $ 67,932     $ 125,973
     Maintenance and services   14,957       16,923     46,187       46,504
 
   
 
   
         Total revenues   35,034       63,335     114,119       172,477
 
   
 
   
                           
Cost of revenues:                          
     License   1,568       2,559     4,669       7,008
     Maintenance and services   4,124       7,299     13,937       19,538
 
   
 
   
         Total cost of revenues   5,692       9,858     18,606       26,546
 
   
 
   
              Gross profit   29,342       53,477     95,513       145,931
 
   
 
   
                           
Operating expenses:                          
     Sales and marketing   17,863       25,970     54,040       72,167
     Research and development   8,263       9,257     23,893       26,232
     General and administrative   4,093       5,836     13,110       14,945
     Amortization of goodwill and other intangible assets   2,767       2,767     8,301       8,301
     Executive recruiting costs   -       -     449       -
 
   
 
   
         Total operating expenses   32,986       43,830     99,793       121,645
 
   
 
   
               Income (loss) from operations   (3,644 )     9,647     (4,280 )     24,286
                           
Other income, net   1,452       1,916     4,365       5,558
 
   
 
   
     Income (loss) before income taxes   (2,192 )     11,563     85       29,844
Income tax provision (benefit)   (1,213 )     3,700     29       9,551
 
   
 
   
     Net income (loss) $ (979 )   $ 7,863   $ 56     $ 20,293
 
   
 
   
                           
                           
Per share data:                          
     Basic net income (loss) $ (0.01 )   $ 0.11   $ 0.00     $ 0.28
     Diluted net income (loss) $ (0.01 )   $ 0.10   $ 0.00     $ 0.25
                           
Weighted average shares used in computing:                          
     Basic net income (loss) per share   74,711       73,199     74,390       72,082
     Diluted net income (loss) per share   74,711       78,459     77,498       80,657
                           
                           
See accompanying notes to the condensed consolidated financial statements

4


Table of Contents

MICROMUSE INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands)
(Unaudited)

  Nine months ended  
  June 30,  
 
 
  2002     2001  
 
   
 
Cash flows from operating activities:              
   Net income $ 56     $  20,293  
   Adjustments to reconcile net income to net cash provided by operating activities:              
     Depreciation and amortization   15,089       13,032  
     Amortization of deferred employee compensation   -       42  
     Compensation expense related to issuance of warrant   170       -  
     Tax benefit related to exercise of stock options   56       2,728  
     Deferred income taxes   -       2,100  
    Changes in operating assets and liabilities:              
       Billed receivables, net   8,207       (16,170 )
       Prepaid expenses and other current assets   5,550       (3,086 )
       Accounts payable   (4,430 )     1,802  
       Accrued expenses   (11,628 )     16,182  
       Income taxes payable   (13 )     4,601  
       Deferred revenue   4,226       11,830  
 
   
 
         Net cash provided by operating activities   17,283       53,354  
 
   
 
               
Cash flows from investing activities:              
   Capital expenditures   (2,450 )     (9,455 )
   Investment purchases, net   (46,685 )     (32,211 )
 
   
 
    Cash used in investing activities   (49,135 )     (41,666 )
 
   
 
               
Cash flows from financing activities:              
   Proceeds from issuance of common stock   4,888       24,388  
 
   
 
     Net cash provided by financing activities   4,888       24,388  
 
   
 
Effects of exchange rate changes on cash and cash equivalents   (945 )     (140 )
 
   
 
Net increase (decrease) in cash and cash equivalents   (27,909 )     35,936  
Cash and cash equivalents at beginning of period   138,581       83,679  
 
   
 
Cash and cash equivalents at end of period   $ 110,672     $  119,615  
 
   
 

See accompanying notes to the condensed consolidated financial statements


5


Table of Contents

MICROMUSE INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

Note 1.  Basis of Presentation

The condensed consolidated financial statements are the unaudited historical financial statements of Micromuse Inc. and subsidiaries (the “Company”) and reflect all adjustments (consisting only of normal recurring adjustments) that, in the opinion of management, are necessary for a fair presentation of interim period results. These condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes thereto included in the Company’s Form 10-K as filed with the Securities and Exchange Commission on December 21, 2001. The September 30, 2001, consolidated balance sheet included herein was derived from audited financial statements, but does not include all disclosures, including notes, required by generally accepted accounting principles.

The results of operations for the current interim period are not necessarily indicative of results to be expected for the entire current year or other future interim periods.

Reclassifications
Certain reclassifications, none of which affected net income, have been made to prior amounts to conform to the current period presentation.

Use of Estimates
The preparation of condensed consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from these estimates.

Cash Equivalents
The Company considers all highly liquid instruments with a maturity at purchase of three months or less to be cash equivalents.

Shareholders’ Equity and Stock Split
All share and per-share numbers herein reflect the 2 for 1 stock split of our common stock that occurred for stockholders of record on December 5, 2000.


6


Table of Contents

MICROMUSE INC.

Per Share Data
Basic per share amounts are calculated using the weighted-average number of common shares outstanding during the period. Diluted per share amounts are calculated using the weighted-average number of common shares outstanding during the period and, when dilutive, the weighted-average number of potential common shares from the exercise of outstanding options and warrants to purchase common stock using the treasury stock method. Excluded from the computation of net loss per share for the three months ended June 30, 2002, was a warrant to acquire 54,321 shares of common stock at $5.42 per share, and options to acquire approximately 12.6 million shares of common stock, with a weighted average exercise price of $23.18 per share, because their effect would be anti-dilutive. A reconciliation of the numerators and denominators used in the basic and diluted net income per share amounts follows (in thousands):

  Three months ended   Nine months ended
  June 30,   June 30,
 
 
  2002     2001   2002   2001
 
   
 
 
                         
Numerator for basic and diluted net income (loss) $ (979 )   $ 7,863   $ 56   $ 20,293
 
   
 
 
Denominator for basic net income (loss) per share – weighted-average shares outstanding   74,711       73,199     74,390     72,082
     Dilutive effect of:                        
        Common stock options   -       5,260     3,054     8,575
        Warrant   -       -     54     -